- Home
- TARA vs SCOR Comparison
TARA vs SCOR Comparison
Compare TARA & SCOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARA
- SCOR
- Stock Information
- Founded
- TARA N/A
- SCOR 1999
- Country
- TARA United States
- SCOR United States
- Employees
- TARA N/A
- SCOR 1250
- Industry
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- SCOR Business Services
- Sector
- TARA Health Care
- SCOR Consumer Discretionary
- Exchange
- TARA Nasdaq
- SCOR Nasdaq
- Market Cap
- TARA 39.6M
- SCOR 33.6M
- IPO Year
- TARA N/A
- SCOR 2007
- Fundamental
- Price
- TARA $1.85
- SCOR $6.68
- Analyst Decision
- TARA Strong Buy
- SCOR Buy
- Analyst Count
- TARA 2
- SCOR 3
- Target Price
- TARA $24.00
- SCOR $12.83
- AVG Volume (30 Days)
- TARA 119.0K
- SCOR 15.8K
- Earning Date
- TARA 11-01-2024
- SCOR 11-04-2024
- Dividend Yield
- TARA N/A
- SCOR N/A
- EPS Growth
- TARA N/A
- SCOR N/A
- EPS
- TARA N/A
- SCOR N/A
- Revenue
- TARA N/A
- SCOR $358,733,000.00
- Revenue This Year
- TARA N/A
- SCOR N/A
- Revenue Next Year
- TARA N/A
- SCOR $3.99
- P/E Ratio
- TARA N/A
- SCOR N/A
- Revenue Growth
- TARA N/A
- SCOR N/A
- 52 Week Low
- TARA $1.04
- SCOR $6.12
- 52 Week High
- TARA $5.24
- SCOR $20.97
- Technical
- Relative Strength Index (RSI)
- TARA 52.07
- SCOR 43.15
- Support Level
- TARA $1.60
- SCOR $6.47
- Resistance Level
- TARA $1.85
- SCOR $6.88
- Average True Range (ATR)
- TARA 0.13
- SCOR 0.31
- MACD
- TARA 0.02
- SCOR 0.05
- Stochastic Oscillator
- TARA 52.58
- SCOR 34.43
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
About SCOR comScore Inc.
comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each, across media platforms. The platforms measure include televisions, mobile devices, computers, tablets, CTV devices and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada and Others. It provides solutions for Automotive, Digital Media, Financial Services, FMCG, Pharmaceutical , Retail, Technology and Travel.